Novo Nordisk invests billions in new labs

Pharmaceutical company Novo Nordisk is expanding in Denmark, beginning construction on a 55,000 square meter laboratory complex in southern Hillerød, where they already employ 4000 staff. Set to be completed in 2027, the project will cost 2.9 billion Danish kroner. The laboratories will ensure the quality of Novo Nordisk’s medicines to meet growing global demand. Senior Vice President Erik Lorin Rasmussen emphasized the facility’s critical role in maintaining product quality and regulatory compliance. Present at the groundbreaking ceremony were Hillerød Mayor Kirsten Jensen and Minister of Industry Morten Bødskov. Novo Nordisk, which employed close to 29,000 people in Denmark at the end of last year, had added several thousand jobs and invested 22 billion kroner in 2023 including in Kalundborg, Hillerød, and Bagsværd, with future factory plans in Køge and Odense.